These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 17703091

  • 1. Relation between serum calcium, phosphate, parathyroid hormone and 'nondipper' circadian blood pressure variability profile in patients with normal renal function.
    Kanbay M, Isik B, Akcay A, Ozkara A, Karakurt F, Turgut F, Alkan R, Uz E, Bavbek N, Yigitoglu R, Covic A.
    Am J Nephrol; 2007; 27(5):516-21. PubMed ID: 17703091
    [Abstract] [Full Text] [Related]

  • 2. Relation between serum thyroid hormone and 'nondipper' circadian blood pressure variability.
    Kanbay M, Turgut F, Karakurt F, Isik B, Alkan R, Akcay A, Yigitoglu R, Covic A.
    Kidney Blood Press Res; 2007; 30(6):416-20. PubMed ID: 17960070
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism.
    Feldstein CA, Akopian M, Pietrobelli D, Olivieri A, Garrido D.
    Clin Exp Hypertens; 2010 May; 32(3):154-8. PubMed ID: 20504122
    [Abstract] [Full Text] [Related]

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 5. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
    Rodrigo Calabia E, Ruiz San Millán JC, Gago M, Ruiz Criado J, Piñera Haces C, Fernández Fresnedo G, Palomar R, Gómez Alamillo C, Martín de Francisco AL, Arias M.
    Nefrologia; 2009 Nov; 29(2):143-9. PubMed ID: 19396320
    [Abstract] [Full Text] [Related]

  • 6. Uric acid and nocturnal nondipping in hypertensive patients with normal renal function.
    Afsar B, Elsurer R, Ozdemir FN, Sezer S.
    J Nephrol; 2008 Nov; 21(3):406-11. PubMed ID: 18587730
    [Abstract] [Full Text] [Related]

  • 7. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L, Marco MP, Martínez I, Rue M, Borràs M, Martín ML, Sarró F, Valdivielso JM, Fernández E.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [Abstract] [Full Text] [Related]

  • 8. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL.
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [Abstract] [Full Text] [Related]

  • 9. [Correlations between the levels of vitamin D, parathormone, calcium, blood phosphates in patients with chronic kidney disease not treated with kidney replacement therapy].
    Smirnov AV, Volkov MM, Galkina OV, Zhloba AA, Emanuél' VL.
    Ter Arkh; 2009 Apr; 81(8):49-52. PubMed ID: 19799200
    [Abstract] [Full Text] [Related]

  • 10. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
    Evenepoel P, Claes K, Kuypers D, Maes B, Vanrenterghem Y.
    Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
    [Abstract] [Full Text] [Related]

  • 11. Association between nondipper behavior and serum calcium in hypertensive patients with mild-to-moderate chronic renal dysfunction.
    Feldstein C, Akopian M, Olivieri AO, Garrido D.
    Clin Exp Hypertens; 2012 Aug; 34(6):417-23. PubMed ID: 22471782
    [Abstract] [Full Text] [Related]

  • 12. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C.
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [Abstract] [Full Text] [Related]

  • 13. Serum phosphate in white-coat hypertensive patients: focus on dipping status and metabolic syndrome.
    Vyssoulis G, Karpanou E, Tzamou V, Kyvelou SM, Michaelidis A, Stefanadis C.
    Hypertens Res; 2010 Aug; 33(8):825-30. PubMed ID: 20505672
    [Abstract] [Full Text] [Related]

  • 14. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND, Polkinghorne KR, Kerr PG, Somerville CA, Agar JW.
    Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
    [Abstract] [Full Text] [Related]

  • 15. Vascular changes in chronic renal disease patients with secondary hyperparathyroidism.
    Bortotolotto LA, Costa-Hong V, Jorgetti V, Consolim-Colombo F, Rosa K, Silva BC, Krieger EM, De Lima JJ.
    J Nephrol; 2007 Apr; 20(1):66-72. PubMed ID: 17347976
    [Abstract] [Full Text] [Related]

  • 16. Use of plasma B-type natriuretic peptide level to identify asymptomatic hypertensive patients with abnormal diurnal blood pressure variation profiles: nondippers, extreme dippers, and risers.
    Nakatsu T, Shinohata R, Mashima K, Yuki Y, Nishitani A, Toyonaga S, Ogawa H, Hirohata S, Usui S, Kusachi S.
    Hypertens Res; 2007 Jul; 30(7):651-8. PubMed ID: 17785934
    [Abstract] [Full Text] [Related]

  • 17. [Intact whole bioactive parathormone: problems arising from comparing different methods].
    Marangella M, Migliardi M, Dutto F, Mengozzi G, Marranca D, Bagnis C, Berutti S, Gallone G, Aimo G, Ramello A, Fonzo D.
    G Ital Nefrol; 2002 Jul; 19(4):467-75. PubMed ID: 12369051
    [Abstract] [Full Text] [Related]

  • 18. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
    Moosgaard B, Vestergaard P, Heickendorff L, Mosekilde L.
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
    [Abstract] [Full Text] [Related]

  • 19. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate.
    Davidson MB, Hix JK, Vidt DG, Brotman DJ.
    Arch Intern Med; 2006 Apr 24; 166(8):846-52. PubMed ID: 16636209
    [Abstract] [Full Text] [Related]

  • 20. Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels.
    Jubiz W, Canterbury JM, Reiss E, Tyler FH.
    J Clin Invest; 1972 Aug 24; 51(8):2040-6. PubMed ID: 5054463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.